Background: London accounts for nearly half of the national burden of tuberculosis. The incidence of tuberculosis has more than doubled in London in the last 15 years.
INTRODUCTION
Tuberculosis (TB) is increasing across the UK and is a particular public health concern in London. In England and Wales (E&W), the incidence of TB declined throughout most of the 20th century. [1] However, since the mid-1980's this trend has reversed. [2] Contributing to the rise are changing patterns of immigration, [3] [4] [5] [6] increased homelessness [3] [7] [8] [9] [10] [11] and HIV infection [3] [9] as well as an ageing population. Over forty percent of TB cases in E&W live in London. [2] Research published in the last few years shows that the incidence of TB in London is especially high in recently arrived immigrants; [2] [12] and varies significantly by borough. [13] This paper provides a summary of the changing epidemiology of TB in London over the past decade and a half.
METHODS
London data from enhanced TB surveillance (ETS) 1999-2003, the national TB surveys of 1993 [14] and 1998 [2] and TB notifications were compared and analysed. Since 2002 surveillance in London has been possible through the Health Protection Agency London TB Register (LTBR) which is a web-based system used in every TB clinic across the city. Validation of this data is on-going at both regional and national levels and methodologies for the 1993 and 1998 national TB surveys have been described elsewhere. [2] [14] Estimates of population denominator data were obtained from the 1991 and 2001 Census. Geographic information systems were used to plot cases by postcode and borough.
RESULTS

Cases, age and sex
In 2003, London accounted for 45% of the national TB burden; 3048 TB cases were reported via ETS (the LTBR). This represents an incidence of 41.3 per 100,000, five times higher than the rest of England and Wales at 8.2 per 100,000. Over the last 15 years TB notifications have doubled in London from just over 20 per 100,000 in 1987; but have remained fairly constant in the rest of England and Wales (Figure 1 ).
The age distribution of new cases of TB in London has changed over the past seven years ( Figure 2 ). TB notifications rose most rapidly in the 25-34 year old age group and remain highest in this group. In 2003 the incidence of TB in 25-34 year old men was 60 per 100,000 and for women 52 per 100,000 ( Figure 3 ). Since 2001 rates have fallen slightly in those over 45.
communities. Hot spots have not changed much over the time period of our review. (Figure 4 ). 
Ethnicity and country of birth
In 2003, 86% of TB cases in London were from a non-white ethnic group; 35% were black African and 31% were from the Indian Subcontinent. Between 1999 and 2003 the proportion of TB notifications in the white population fell, but rose in nearly all other ethnic groups. In the past 5 years TB in black African communities has risen significantly. In 2003 the TB incidence in black Africans was 283 per 100,000 compared to 141, 141 and 8 for Pakistanis, Indians and whites respectively (figure 5). The incidence in black Africans aged 25-44 was 407/100,000 compared to 41/100,000 for all ages and ethnic groups across London and 8.2/100,000 across the rest of England and Wales. In black Africans TB is found more commonly in new entrants and those who have lived in the UK for less than 5 years.
Enhanced TB Surveillance (ETS) data from the LTBR show that the majority of TB cases in the white population are aged over 45 years, while in black African communities most cases are aged 25-44 years and in the Indian Sub Continent there is a mix of middle and older aged people ( Figure 6 ).
The vast majority of TB cases in London are born abroad ( Figure 7 ). In 2003, 75% were born abroad (where place of birth was known). This percentage has risen steadily since 1993 from 55%. In the last 10 years India has remained the most commonly reported country of birth for TB cases born abroad. The other top ten countries have remained similar apart from a substantial rise in Somalian cases between 1993 and 1998, and since 1999 a rise in Afghan cases.
In 2003, 46% of TB cases born abroad had entered the UK within the last 5 years and 27% had lived in the UK for more than 10 years. On further analysis of those born abroad in the two largest ethnic minority subgroups, black Africans were more likely to be new entrants or resident in the UK for less than 5 years (52%) whereas TB patients from the Indian Subcontinent were more likely to have lived in the UK for over 10 years (Fig 8) .
TB and HIV
Co-infection with TB and HIV is an increasing problem in London (see Table 1 ). In 1993, 3.3% of TB cases were co-infected; by 1998 this had risen to 5.4% [15] and by 2001 the rate was 6.5% (personal communication: Valerie Delpech, HPA Colindale, 2005) . This is thought to be an underestimate. Reports from London hospitals suggest rates of co-infection are as high as 17 to 25%. [16] [17] It has been estimated that over three-quarters of the national HIV and TB co-infected population live in London, the majority of whom are black African. [15] Between 1993 and 1998, co-infection increased by a factor of 2.5 in black Africans and by a factor or 0.6 in whites. [15] It was estimated that between 1993 and 1998, 11% of the rise in London's TB cases could be attributed to HIV. [15] It is important in London to offer and recommend HIV testing for all TB cases so that both infections can be properly treated. Drug Resistant TB Both isoniazid resistant and multi-drug resistant (MDR) TB are bigger problems in London than elsewhere in England and Wales. In 2003, 9.4% of isolates were isoniazid resistant in London ( Figure 9 ) compared to 7.5% nationally. Rates of isoniazid resistant TB were relatively stable until 2000 but have risen slightly since then due mainly to a large outbreak of isoniazid mono-resistant TB. [18] Over the past five years rates of MDR TB have been around 1-1.5% in London with just a slight rise to 2% in 2003 (the most recent year for which data is available).
Outcome of Treatment
In 2003 treatment outcome data was available through the LTBR. Patients notified during 2002 were followed up one year after commencing treatment. 82% had completed a full course of treatment, 10% had not completed treatment and 8% were either lost to followup or had an unknown outcome. Of the 10% not completing treatment, two-thirds had died and for just under half of these TB caused or contributed to death.
Molecular Epidemiology of TB
Research published in 2002 using molecular typing showed that TB in London was mainly caused by reactivation or importation of infection by recent immigrants. [19] New infections were common in people with recognised risk factors such as alcoholism or HIV. The main findings were the importance of preventive interventions and early diagnosis in immigrants, along with thorough contact tracing and monitoring of treatment outcome in groups at higher risk of new infection. This molecular study was conducted in the late 1990s before a large outbreak of drug resistant TB in North London; its findings may now have changed. The outbreak has emphasized the vulnerability to recent new infection of groups such as drug users and prisoners in London. [18] Risk groups A cross sectional survey performed in London in July 2003 found the overall prevalence of TB to be 27 per 100,000 but reached 788 in people sleeping rough or using direct access homeless hostels, 550 in prisoners, 172 in drug users and 878 in patients diagnosed HIV positive. This survey demonstrated a prevalence of disease in recent migrants of 149/100,000 and among refugees and asylum seekers of 92/100,000. [20] DISCUSSION TB is an increasing problem in London. Over the last 15 years its incidence has doubled to 41.3 per 100,000 and continues to rise. In 2003, 3048 cases were reported via enhanced TB surveillance, 45% of the national total. A discrepancy exists between statutory notifications and LTBR data as shown in Figure 1 . In 2003, 2745 TB cases were formally notified in London compared to 3048 notified via the LTBR. Enhanced TB surveillance is likely to better reflect the true incidence of TB as it undergoes more rigorous validation than statutory notifications. Caution has been advised in the interpretation of statutory notification data. [21] The incidence of TB varies substantially between different ethnic groups. In 2003, 86% of TB cases in London were from an ethnic minority, a reflection of the impact in London of the global epidemic of TB. [22] Three quarters of cases were born abroad in countries where TB incidence is much higher. The importance of this for prevention and control is that primary care / community services need to be increasingly aware of at risk groups and target case finding and treatment appropriately. We have shown that incidence varies across London boroughs from <10/100,000 to 96/100,000 (nearly 10 times the national average) and in recent years London's TB 'hot spots' have remained largely unchanged although a few areas have seen increases of up to fivefold. The hot spots are not just inner city districts, but include suburban areas with well-established ethnic communities. Immigration patterns to the UK have changed over time, [6] with more people arriving from the Indian Subcontinent over 10 years ago and young Africans more recently. Africans made up 41% of all asylum applications in 2003, Asians 27%. [23] Our results reflect the changing patterns of immigration (with higher rates of TB in older Asians with longer residency and younger more recently arrived Africans) and highlight the fact that it is not just recently arrived immigrants who are developing TB. TB control and prevention strategies need to be mindful of this and provide information, diagnosis and treatment to newly arrived immigrants as well as for more established ethnic communities.
Approximately 7 million people live in London [Census data 2001] . From 1991 to 2001 the proportion of people from an ethnic minority increased from 20% to 29%. The increase was evident in all ethnic minority groups with the greatest increase seen for black Africans -a doubling from 2.4% to 5.4%. As a reflection of this, TB in black African communities has risen significantly in the past 5 years. The current notification rate for all ages is 283/100,000 and for the 25-44 age group 407/100,000. In black Africans TB is found more commonly in new entrants and those who have lived in the UK for less than 5 years. This suggests that a greater understanding of this group is needed and more resources to assess and diagnose newly arrived black Africans in addition to further prevention work.
The rise in TB notification in London is likely to have many causes. Apart from the changing patterns of immigration other factors that impact on TB epidemiology include; increased detection through increased staff to patient ratios and heightened awareness of TB in both the public and health care staff; increased opportunities for international travel with exposure to TB in high incidence countries; HIV infection in London at an all time high and the emergence of drug resistant TB -rising slowly and mainly due to a large outbreak of isoniazid mono-resistant TB. [18] In addition incidence and prevalence rates of TB are documented to be high in the homeless [8] [11] and prison populations; [18] [20] groups that are often marginalised and difficult to reach and engage. [24] Can we learn from the New York experience?
In the early 1990's TB had reached epidemic proportions in New York City (NYC). This epidemic differed in several ways to that in London; London has a much higher proportion of TB infected immigrants (London 80% c.f. NYC 25%), a much lower proportion of HIV co-infected TB patients (London 6.5% c.f. NYC 38%) and lower levels of MDR TB (London 1.2% c.f. New York 19%). [25] However there are similarities between the two epidemics, such as similar numbers of cases at the epidemic peak and a higher prevalence in lower socio-economic classes, ethnic minorities and the homeless. NYC's epidemic was brought under control by broadening treatment regimes, using directly observed therapy and structured guidelines for control and prevention. [26] The reduction in cases in NYC has largely been confined to those born in the US. [27] As TB in London is mostly found in non-UK born ethnic minorities the lessons learnt in New York may not all be appropriate. However, New York suffered a sub-epidemic of drug resistant TB and lessons learnt from containment of this might be helpful for London. Similarly for TB patients co-infected with HIV, London might benefit from reviewing New York's policies; as the fastest growing group of TB patients are 25-34 year old black Africans who also have the highest rates of co-infection.
What does all this mean for London?
TB in London is an increasing public health concern but there have been some service improvements reported in each of London's five sectors together with the creation of multidisciplinary TB networks. Service improvements include greater monitoring of treatment completion; an increase in the number of TB nurses and the use, since 2002, of the Health Protection Agency London TB Register (LTBR) in all TB clinics. The LTBR is a web-based electronic case management and surveillance system which allows patients to be tracked as they move between clinics and so improves local service monitoring of patient outcomes. A mobile screening project using targeted digital radiography is being piloted within London to evaluate how this approach could strengthen the screening of defined populations including for example prisoners or hostel dwellers.
Further improvements are possible and these include: improved case finding in high risk groups by screening those known to be at particular risk e.g. residents of hostels for refugees, asylum seekers or the homeless; [11] [28] early detection in new entrants and better access to primary care services; [12] [28] [29] [30] early recognition of symptoms by doctors and patients; a continuing emphasis on treatment continuity and completion with the use of DOT where appropriate to help reduce drug resistance; [26] [31] better diagnosis of TB/HIV co-infection to enable treatment of both conditions appropriately [32] [33] and an increased awareness of the social dimensions of TB control so that health services work more closely with other agencies. [26] [29] [34] The Chief Medical Officer's TB Action Plan [35] published in October 2004 provides a helpful framework to assist TB prevention and control and builds on the existing structures and multi-disciplinary working across London's TB networks. The National Institute for Clinical Excellence (NICE) has recently issued TB clinical diagnosis and management guidelines. [28] These guidelines make recommendations on good practice and attempt to focus NHS resources where they will most effectively combat the spread of TB.
CONCLUSION
The global rise in TB continues and TB in London reflects this with increasing rates in ethnic minorities. Drug resistance and co-infection with HIV are growing problems. Control of TB in London needs to improve and ultimately treatment and control services should be tailored to the specific needs of the capital and its at risk groups. This is the time to apply the full weight of political, organisational and individual will, to tackle London's TB problem.
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Updated guidelines for authors of letters to Thorax
H ere at Thorax we believe that letters are the life blood of a journal. Correspondence in response to published articles provides comment and alternative interpretations of data that promote debate, may be unexpected, and add value to the original work. Readers may also take the opportunity to present complementary research findings in such a letter. Moreover, we also publish research letters in Thorax and these are a useful method to present original and important data, or interesting observations that are too limited in scope to require a complete paper. All our letters are cited in PubMed and linked to the original paper.
We wish to encourage you to submit more letters, to join the debate about the work that we publish, and thus to contribute to the vibrancy of our wonderful specialty. To facilitate this we have updated the author guidelines for letters in Thorax. The changes are also an attempt to make our letters page more timely, more up to date and more succinct, which will enable us to publish more of your correspondence. We have previously trialled a feature where ''rapid responses'' to a published article were posted online. However, we felt that all correspondence about published articles should be submitted for consideration of publication in the full print journal and thus we discontinued the rapid responses feature.
CORRESPONDENCE ABOUT PUBLISHED PAPERS
For responses to published articles your letter must reach us by the end of the following calendar month (for example, by the end of July for letters referring to articles in the June print issue) and be a maximum length of 400 words, with one figure or table and no more than five references. However, Thorax has an online repository facility so additional information including methodology, data and tables could be placed in the online supplement. You can also get a head start on debating our published papers by viewing accepted work using our Online First facility in which papers are published online in full as soon as they have been accepted for publication. All letters are submitted through our online submission Bench Press system and we always invite the corresponding author of a paper to comment on letters in response to their work. However, as we receive more letters than we can publish, we reject a proportion of letters written in response to published papers. In this case, we always endeavour to supply the authors of a letter with the response received from the original authors.
RESEARCH LETTERS
For original research letters the maximum length will be 500 words, again with no more than one figure or table and five references. As for correspondence, authors may also make use of the online supplement. All original letters are first seen by one of us, and some of these may be rejected without further review if we feel they do not reach a standard for publication or are not of sufficient interest to the readership of the journal. We send out the remainder of original research letters for further peer review, usually to two reviewers. These letters will then be discussed by the Editors at the regular editorial committee meetings in the same way that we discuss all potentially acceptable papers. However, as with original papers, we also have to reject a significant proportion of the research letters submitted.
Letters pages in the journal are important and help us directly to involve you, our readers. Please keep debates alive in respiratory medicine by writing to Thorax with your comments about the work we have published. This will surely benefit our specialty and stimulate further research.
